Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sanquin Research & Blood Bank Divisions |
---|---|
Information provided by: | Sanquin Research & Blood Bank Divisions |
ClinicalTrials.gov Identifier: | NCT00440921 |
Condition | Intervention |
---|---|
Total Knee-Replacement Total Hip-Replacement |
Drug: Single donor Allogenous Fibrin Sealant |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Randomized Clinical Trial for Fibrin Sealant in Knee- and Hip Surgery |
Estimated Enrollment: | 578 |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | January 2008 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Coen van Delden, PhD | c.vandelden@sanquin.nl | |
Contact: Janny de Wildt-Eggen, PhD | j.dewildt@sanquin.nl |
Study Chair: | Coen van Delden, PhD | Sanquin Blood Bank North East Region |
Study ID Numbers: | RP06.008 |
Study First Received: | February 26, 2007 |
Last Updated: | February 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00440921 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
fibrin sealnat knee replacement hip replacement woud healing |
blood loss clinical trial randomized |
Fibrin Tissue Adhesive Hemorrhage |
Coagulants Therapeutic Uses Hematologic Agents Pharmacologic Actions Hemostatics |